% | $
Quotes you view appear here for quick access.

Edwards Lifesciences Corp. Message Board

  • donzoab donzoab Dec 10, 2013 6:37 AM Flag

    Here is some good news

    Wells Fargo downgrades EW this morning with a Price Target of 61-63. They were at 85+.
    When analysts throw in the towel investors/traders come back to the stock at lows.
    EW has great products but weak professional management. They need a bigger name CEO who knows how to market and sell this product. Demographics are on their side for the long term as baby boomers continue to age in record numbers and many are just not practicing healthy lifestyles. EW should NOW be using FCF to repurchase shares at this level but if the market goes south so will the stock. I think JNJ should take the opportunity to snap them up here. Management would jump at an $85/share offer even though the long term trends indicate this is worth north of $125. All depends on how they further develop their valves and other new products in the pipeline.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Mussallem has been the CEO since 2000 & the company has consistently maintained high a ROE/ROIC while employing very little debt.

      The recent fears of new entrants into the TAVR market are valid & it remains to be seen if Edwards can hold and preferably increase their market share in TAVR.

      Management is naturally going to issue cautious guidance given the overhang of unresolved class action lawsuits by shareholders regarding Sapiens performance in the market.

      In my opinion; the lawsuits have no merit.

      Sapien has been selling very well into a market with a lot of runway left.

      Institutionals have dumped EW for their own nebulous reasons & have created a nice buying opportunity IMHO.

      If you understand what the company does & believe that historical measures of top quality management predict more of the same; then it's a no brainer to buy right now.

      LEAPS are available if you'd like to leverage some ownership with less risk...

      Sentiment: Strong Buy

79.61+3.27(+4.28%)1:57 PMEST